Sang Froid Labs

Sang_Froid_Labs25 Nov 2019

Trading

₹

0.00 (0.00%)

Lowest Today

Highest Today

Prev. Close

Today’s Open

52 Week High

52 Week Low

BUY

SELL

To Invest in Sang Froid Labs

Sang Froid Labs

Trading

Sang_Froid_Labs25 Nov 2019

₹

0.00 (0.00%)

OverviewFundamentals

Corporate action

Peer comparison

Income Sheet

Balance sheet

Cash flow

Share holding

About Us

Corporate Action

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

All

Dividends

Bonus

Splits

Others

Ex-Date	Type	Description	Record Date
11-Jul-2022	BC	Trading Members of the Exchange are hereby informed that the undermentioned 37 companies that have remained suspended for more than 6 months would be delisted from the platform of the Exchange, with	13-Jul-2022
11-Oct-2019	BC	Pursuant to the provisions of Circular No. SEBI/HO/CFD/CMD/CIR/P/2018/77 dated May 3, 2018 issued by Securities and Exchange Board of India (SEBI) with respect to Standard Operating Procedure (SOP) f	04-Nov-2019
25-Apr-2019	BC	This is to inform you that the Board of Directors of the Company at its meeting held today i.e Thursday, 25th April, 2019, considered and approved the resignation of Ms. Neha Sharma, from the post of	25-Apr-2019
25-Apr-2019	BC	This is to inform you that the Board of Directors of the Company at its meeting held today i.e Thursday, 25th April, 2019, considered and approved the resignation of Ms. Neha Sharma, from the post of	25-Apr-2019
17-Apr-2019	BC	This is to inform you that Mr. Chandubhai Dobariya, Director of the Company will act as Compliance Officer of the Company w.e.f. 17th April, 2019. Further, he is also empower, on behalf of Board of D	17-Apr-2019

No Rights has been declared by Sang_Froid_Labs

Book Closure

Record Date	Split Date	Purpose
13-Jul-2022	-	Trading Members of the Exchange are hereby informed that the undermentioned 37 companies that have remained suspended for more than 6 months would be delisted from the platform of the Exchange, with
04-Nov-2019	-	Pursuant to the provisions of Circular No. SEBI/HO/CFD/CMD/CIR/P/2018/77 dated May 3, 2018 issued by Securities and Exchange Board of India (SEBI) with respect to Standard Operating Procedure (SOP) f
25-Apr-2019	-	This is to inform you that the Board of Directors of the Company at its meeting held today i.e Thursday, 25th April, 2019, considered and approved the resignation of Ms. Neha Sharma, from the post of
25-Apr-2019	-	This is to inform you that the Board of Directors of the Company at its meeting held today i.e Thursday, 25th April, 2019, considered and approved the resignation of Ms. Neha Sharma, from the post of
17-Apr-2019	-	This is to inform you that Mr. Chandubhai Dobariya, Director of the Company will act as Compliance Officer of the Company w.e.f. 17th April, 2019. Further, he is also empower, on behalf of Board of D

Peer Comparison

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Scrip Name	Price	Daily Change	M.Cap (Cr)	1 Year Returns %	P/E (TTM)	PB Ratio
Sang Froid Labs (India) Ltd ₹1.32(0.00/0.00%)	1.32	+0.00	0.67	14.78	0.00	0.24
Computer Point Ltd ₹4.97(+0.34/7.34%)	4.97	+0.34	14.91	136.67	497.00	0.45
Ambalal Sarabhai Enterprises Ltd ₹46.15(-0.25/-0.54%)	46.15	-0.25	353.66	105.48	0.00	9.72
Novartis India Ltd ₹1,039.15(+4.10/0.40%)	1,039.15	+4.10	2,565.74	74.94	26.86	3.65
Aegis Logistics Ltd ₹643.40(-42.90/-6.25%)	643.40	-42.90	22,583.34	63.24	51.19	10.17
Mysore Petro Chemicals Ltd ₹183.50(-0.05/-0.03%)	183.50	-0.05	120.81	59.91	16.18	1.18

Income Sheet

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Standalone

Consolidated

Column	Dec 18	Sep 18	Jun 18	Mar 18	Dec 17	Sep 17
Gross Sales	0.00	0.00	0.00	0.00	0.00	0.10
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	0.00	0.00	0.00	0.00	0.00	0.10
Other Operating Income	0.00	0.00	0.00	0.00	0.00	0.00
Other Income	0.00	0.01	0.00	0.09	0.00	0.00
Total Income	0.00	0.01	0.00	0.09	0.00	0.10
Total Expenditure	0.17	0.11	0.02	0.02	0.01	0.08
PBIDT	-0.17	-0.10	-0.02	0.06	-0.01	0.02
Interest	0.00	0.00	0.00	0.00	0.00	0.00
PBDT	-0.17	-0.10	-0.02	0.06	-0.01	0.02
Depreciation	0.00	0.00	0.00	0.00	0.00	0.00
Tax	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax	0.00	0.00	0.00	0.00	0.00	0.00
Reported Profit After Tax	-0.17	-0.10	-0.02	0.06	-0.01	0.02
Extra-ordinary Items	0.00	0.00	0.00	0.00	0.00	0.00
Adjusted Profit After Extra-ordinary item	-0.17	-0.10	-0.02	0.06	-0.01	0.02

EPS (Unit Curr.)	-0.34	-0.20	-0.03	0.13	-0.01	0.04
EPS (Adj) (Unit Curr.)	0.00	0.00	-0.03	0.13	0.00	0.04
Calculated EPS (Unit Curr.)	-0.34	-0.20	-0.03	0.13	-0.01	0.04
Calculated EPS (Adj) (Unit Curr.)	0.00	0.00	-0.03	0.13	0.00	0.04
Calculated EPS (Ann.) (Unit Curr.)	-1.36	-0.80	-0.13	0.51	-0.05	0.15
Calculated EPS (Adj) (Ann.) (Unit Curr.)	0.00	0.00	-0.13	0.51	0.00	0.15
Book Value (Unit Curr.)	0.00	0.00	0.00	0.00	0.00	0.00
Dividend (%)	0.00	0.00	0.00	0.00	0.00	0.00
Equity	5.10	5.10	5.10	5.10	5.10	5.10
Reserve & Surplus	0.00	0.00	0.00	0.00	0.00	0.00
Face Value	10.00	10.00	10.00	10.00	10.00	10.00

Public Shareholding (No. Of Shares)	0.00	0.00	0.00	0.00	0.00	0.00
Public Shareholding (% in Equity)	0.00	0.00	0.00	0.00	0.00	0.00

Pledged/Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

Non Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

PBIDTM(%)	0.00	0.00	0.00	0.00	0.00	20.00
PBDTM(%)	0.00	0.00	0.00	0.00	0.00	20.00
PATM(%)	0.00	0.00	0.00	0.00	0.00	20.00

Balance Sheet

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Standalone

Consolidated

Column	Mar 18	Mar 17	Mar 16	Mar 15	Mar 14	Mar 13
SOURCES OF FUNDS :
Share Capital	5.10	5.10	5.10	5.10	2.80	2.80
Reserves Total	-2.20	-2.05	-2.02	-2.02	-2.88	-2.89
Equity Share Warrants	0.00	0.00	0.00	0.00	0.00	0.00
Equity Application Money	0.00	0.00	0.00	0.00	0.00	0.00
Total Shareholders Funds	2.90	3.05	3.08	3.08	-0.08	-0.09
Secured Loans	0.35	0.00	0.00	0.00	0.00	0.00
Unsecured Loans	0.00	0.00	0.00	0.00	0.00	0.00
Total Debt	0.35	0.00	0.00	0.00	0.00	0.00
Total Liabilities	3.25	3.05	3.08	3.08	-0.08	-0.09
APPLICATION OF FUNDS :
Gross Block	0.02	0.00	0.00	0.00	0.00	0.00
Less : Accumulated Depreciation	0.00	0.00	0.00	0.00	0.00	0.00
Less:Impairment of Assets	0.00	0.00	0.00	0.00	0.00	0.00
Net Block	0.02	0.00	0.00	0.00	0.00	0.00
Lease Adjustment	0.00	0.00	0.00	0.00	0.00	0.00
Capital Work in Progress	0.00	0.00	0.00	0.00	0.00	0.00
Producing Properties	0.00	0.00	0.00	0.00	0.00	0.00
Investments	2.56	2.56	0.00	0.00	0.00	0.00
Current Assets, Loans & Advances	0.00	0.00	0.00	0.00	0.00	0.00
Inventories	0.00	0.00	0.00	0.00	0.00	0.00
Sundry Debtors	0.00	0.00	0.00	0.00	0.00	0.00
Cash and Bank	0.01	0.01	0.02	0.04	0.01	0.00
Loans and Advances	0.68	0.58	3.16	3.14	0.00	0.00
Total Current Assets	0.68	0.60	3.18	3.18	0.01	0.00
Less : Current Liabilities and Provisions	0.00	0.00	0.00	0.00	0.00	0.00
Current Liabilities	0.01	0.09	0.09	0.09	0.09	0.09
Provisions	0.00	0.01	0.01	0.01	0.00	0.00
Total Current Liabilities	0.01	0.10	0.10	0.10	0.09	0.09
Net Current Assets	0.67	0.49	3.08	3.08	-0.08	-0.09
Miscellaneous Expenses not written off	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax Assets	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax Liability	0.00	0.00	0.00	0.00	0.00	0.00
Net Deferred Tax	0.00	0.00	0.00	0.00	0.00	0.00
Total Assets	3.25	3.05	3.08	3.08	-0.08	-0.09
Contingent Liabilities	0.00	0.00	0.00	0.00	0.00	0.00

Cash Flow

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

PARTICULARS	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014
Cash and Cash Equivalents at Beginning of the year	0.01	0.02	0.04	0.01	0.00
Net Cash from Operating Activities	-0.34	-0.01	-0.01	-3.14	0.01
Net Cash Used In Investing Activities	-0.02	0.00	0.00	0.02	0.00
Net Cash Used In Financing Activities	0.35	0.00	0.00	3.15	0.00
Net Inc./Dec In Cash And Cash Equivalents	-0.01	-0.01	-0.01	0.02	0.01
Cash And Cash Equivalents At End Of The Year	0.01	0.01	0.02	0.04	0.01

Share Holding

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Promoter Shareholding

0.00%

FII Shareholding

0.00%

DII Shareholding

0.00%

Public Shareholding

100.00%

**Promoter pledged shareholding 0.00%

About Sang Froid Labs (India) Ltd

Sang Froid Labs (India) Ltd is in the Trading sector, having a market capitalization of Rs. 0.67 crores. It has reported a sales of Rs. 0 crores and a net profit of Rs. -0.17 crores for the quarter ended December 2018. The company management includes , Mehul Bhuva,Shivani Shukla,Chandubhai Nanubhai Dobariya (Sang Froid Labs (India) Ltd) among others.

Chairman

Registered office

4th Floor Plot No 158,Phase-II Shazada Bagh,New Delhi,New Delhi,110035

FAX :

Background

Incorporation Year1994

Face Value₹10

Market Lot1

How to buy Sang Froid Labs shares on nse?

To buy Sang Froid Labs shares in Motilal Oswal, you just need to open a demat account and get your KYC documents verified

What is the Sang Froid Labs share price today?

The Sang Froid Labs shares price on nse is Rs.1.32 today.

What is the market cap of Sang Froid Labs shares on BSE ?

The company has a market capitalization of Rs.0.67Cr

What is the PE & PB ratio of Sang Froid Labs shares ?

PE is 0 and PB is 0.24

What is the 52 Week High and Low of Sang Froid Labs shares?

Sang Froid Labs stock price high: Rs.1.32 Sang Froid Labs stock price low: Rs.0